Clearside Biomedical, Inc.
CLSD · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$34,352 | -$32,485 | -$32,947 | $376 |
| Dep. & Amort. | $226 | $67 | $145 | $178 |
| Deferred Tax | $0 | $0 | $0 | $0 |
| Stock-Based Comp. | $4,513 | $4,202 | $4,884 | $5,054 |
| Change in WC | -$1,677 | $720 | $11,236 | -$15,343 |
| Other Non-Cash | $6,592 | $9,361 | $3,317 | -$998 |
| Operating Cash Flow | -$24,698 | -$18,135 | -$13,365 | -$10,733 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -$977 | -$1,777 | -$246 | $0 |
| Net Acquisitions | $0 | $0 | $0 | $0 |
| Inv. Purchases | -$16,911 | $0 | $0 | $0 |
| Inv. Sales/Matur. | $17,250 | $0 | $0 | $0 |
| Other Inv. Act. | $0 | $0 | $0 | $0 |
| Investing Cash Flow | -$638 | -$1,777 | -$246 | $0 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $0 | $0 | $30,638 | $0 |
| Stock Issued | $16,389 | $1,666 | $695 | $23,283 |
| Stock Repurch. | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | $47 | -$1,252 | $0 | $499 |
| Financing Cash Flow | $16,436 | $414 | $31,333 | $23,782 |
| Forex Effect | $0 | $0 | $160 | $0 |
| Net Chg. in Cash | -$8,900 | -$19,498 | $17,882 | $13,049 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $28,920 | $48,418 | $30,696 | $17,647 |
| End Cash | $20,020 | $28,920 | $48,418 | $30,696 |
| Free Cash Flow | -$25,675 | -$19,912 | -$13,611 | -$10,733 |